Jacobs Levy Equity Management, Inc Foghorn Therapeutics Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 129,331 shares of FHTX stock, worth $556,123. This represents 0.0% of its overall portfolio holdings.
Number of Shares
129,331
Previous 184,304
29.83%
Holding current value
$556,123
Previous $1.06 Million
13.69%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding FHTX
# of Institutions
81Shares Held
33.3MCall Options Held
8.7KPut Options Held
2.4K-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$54.5 Million20.03% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$22.8 Million1.57% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.03MShares$13 Million0.52% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$9.88 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.73MShares$7.45 Million0.0% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $179M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...